InSens4™

A sensing platform that presents a solution to address key problems plaguing the biomanufacturing industry.

Enabling Growth in the Biomanufacturing

AB has developed the world’s first in-line sensor, InSens4™, capable of monitoring multiple key parameters (Glucose, Lactate, Osmolality, and pH) continuously. This sensor will provide continuous vital data on concentrations of critical parameters that will enable biopharmaceutical companies (end-users) to ensure tighter process control.


The InSens4™ Advantage


  • Increased productivity through better process understanding and higher product yield.
  • Eliminating manufacturing failures and contamination risks during drug production.
  • Lowering the cost of drug development and manufacturing processes.

InSens4™ offers

  • Multi-analyte monitoring on one single probe
  • Simple to use: plug, play, calibrate. That’s it.
  • Compatible with Autoclave and Gamma sterilization
  • Fits standard 12mm port on any bioreactor

  • Easy Connectivity to third-party industrial controllers
  • User-friendly software
  • Biocompatible, USP Class VI materials
  • Robust and consistent

Patents and Awards

Key Patents

  • US10448895B2, Sensor Systems
  • US20160215253A1, Multi-analyte sensing using hydrogels and magnetometers
  • US20190231218A1, Hydrogel sensor assembly

Active Awards

  • NSF: SBIR Phase II: In-line sensor for monitoring monoclonal antibody production based on hydrogels containing peptide aptamers.
  • NIIMBL: Multi-Analyte In-line Sensor for Biomanufacturing Applications Based on Analyte-Responsive Smart Hydrogels.
  • ARMI: Multi-Analyte, Non-Invasive Sensor for Cell Biomanufacturing